# A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab

> clinical trial · VERIFIED · 2026-08-03

Status: ACTIVE_NOT_RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Extensive Stage Small Cell Lung Cancer

- Company: Novartis Pharmaceuticals
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05142696

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.